STIM — Neuronetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1227636 ·
Last close
$1.22
Market Cap
$84.90M
52W High
$2.47
52W Low
$0.80
ADV30
2,608,753
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,454,000 | 16,154,000 | -8,995,000 | -10,790,000 | 125,440,000 | 13,214,000 | 108,380,000 |
| Dec 2025 | 41,777,000 | 21,704,000 | -5,043,000 | -7,158,000 | 141,551,000 | 28,134,000 | 115,311,000 |
| Sep 2025 | 37,297,000 | 17,108,000 | -7,321,000 | -9,045,000 | 145,465,000 | 27,971,000 | 114,105,000 |
| Jun 2025 | 38,108,000 | 17,758,000 | -8,058,000 | -10,120,000 | 134,650,000 | 10,969,000 | 103,143,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,374,000
Investing CF
$-801,000
Financing CF
$35,850,000
CapEx
$-801,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.59
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-458,787,000
Inventory
$4,327,000
Receivables
$16,893,000
ST Investments
$225,000
EBIT TTM
$-31,520,000
Pretax Income TTM
$-39,120,000
Interest Exp TTM
$7,600,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$151,636,000
EBITDA
$-25,778,000
Free Cash Flow
$-4,582,000
Enterprise Value
$159,474,400
Total Cash
$13,214,000
Total Debt
$85,388,000
Shares Out
69,587,840
Trailing EPS
$-0.54
Book Value
$0.19
ROE
-131.6%
ROA
-13.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 149,157,000 | -31,436,000 | -38,998,000 | 141,551,000 | 115,311,000 | — | -20,374,000 |
| Dec 2024 | 74,890,000 | -34,563,000 | -43,708,000 | 140,903,000 | 109,104,000 | — | -30,997,000 |
| Dec 2023 | 71,348,000 | -30,554,000 | -30,189,000 | 115,831,000 | 81,641,000 | — | -32,038,000 |
| Dec 2022 | 65,206,000 | -35,111,000 | -37,159,000 | 116,884,000 | 59,824,000 | — | -30,739,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NRXS | Neuraxis, INC | $86.69M | $7.00 | — |
| OM | Outset Medical, Inc. | $81.56M | $4.40 | — |
| SPAI | Safe Pro Group Inc. | $91.75M | $4.45 | — |
| PYPD | PolyPid Ltd. | $92.80M | $4.84 | — |
| STSS | Sharps Technology Inc. | $77.03M | $1.82 | — |
News headlines (Yahoo Finance, 1h cache)
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
2026-05-14 12:32 · Yahoo
Neuronetics Q1 Earnings Call Highlights
2026-05-05 21:07 · Yahoo
Neuronetics, Inc. Q1 2026 Earnings Call Summary
2026-05-05 20:55 · Yahoo
Neuronetics (STIM) Q1 2026 Earnings Transcript
2026-05-05 20:20 · Yahoo
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 13:15 · Yahoo
Neuronetics Reports First Quarter 2026 Financial and Operating Results
2026-05-05 11:50 · Yahoo
How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target
2026-05-02 14:14 · Yahoo
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-04-29 20:30 · Yahoo
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
2026-04-21 12:30 · Yahoo
How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions
2026-04-18 11:07 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-05-20 12:39:34 | 2026-05-19 | Chernett Jorey | 10% | P - Purchase | 1.17 | 100000 | 117000 |